5Fisher RI, Gaynor ER, Dahlbeg S, et al. Comparison of a standard regimen (CHOP) with three intensive chemothera- py regimens for advanced non - Hodgkin's lymphoma [ J ]. N Engl J Med,1993,328(14) :1002 -1006.
6Coiffier B, Lepage E, Briere J. CHOP chemotherapy plus Rituximab compared with CHOP alone in elderly patients with diffuse large - B - cell lymphoma [ J ]. N Engl J Med, 2002,346 (4) :235 - 242.
7McLaughlin P, Grillo- Lopez AJ, Link BK, et al. Rituximab chimeric anti- CD20 monoclnnal antibody therapy for relapsed indolent lymphoma, half of patients respond to a four - dose treatment program [ J ]. J Clin Oncol, 1998,16 : 2825 - 2833.
8Plosker GL, Figgitt DP. Rituximab: a review of its use in non - Hodgkin's lymphoma and chronic lymphocytic leukaemia[ J ]. Drugs, 2003,63 ( 8 ) :803 - 843.
9Skrabs C, Muller C, Agis H, et al. Treatment of HBV - carrying lymphoma patients with Rituximab and CHOP: a diagnostic and therapeutic challenge [ J ]. Leukemia, 2002, 16(9 ) : 1884 - 1886.
